Emergent BioSolutions | EBS - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Akebia Therapeutics USD 502M 75M 2025-03
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 341M 4M 2025-09
ANI Pharmaceuticals USD 1.77B 269M 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Coherus Biosciences USD 94M 65M 2025-03
Emergent BioSolutions USD 125M 51M 2023-12
Exelixis USD 11.75B 959M 2025-12
Glaxosmithkline GBP 86.88B 7.29B 2025-09
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pacira USD 1.06B 94M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12